[Federal Register Volume 87, Number 10 (Friday, January 14, 2022)]
[Notices]
[Page 2444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00697]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Clinical Trials to Test the Effectiveness of 
Treatment, Preventive, and Services Interventions (R01, 
Collaborative R01, R34).
    Date: February 17, 2022.
    Time: 9:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699, 
<a href="/cdn-cgi/l/email-protection#452730373631202c2b28200528242c296b2b2c2d6b222a33"><span class="__cf_email__" data-cfemail="147661666760717d7a79715479757d783a7a7d7c3a737b62">[email protected]</span></a>.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Early Stage Clinical Trials and Development of 
Pharmacologic or Device-Based Interventions.
    Date: February 28, 2022.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699, 
<a href="/cdn-cgi/l/email-protection#432136313037262a2d2e26032e222a2f6d2d2a2b6d242c35"><span class="__cf_email__" data-cfemail="751700070601101c1b18103518141c195b1b1c1d5b121a03">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental 
Health Research Grants, National Institutes of Health, HHS)

    Dated: January 11, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-00697 Filed 1-13-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>